Hypertrophic cardiomyopathy trials in Poland

In Poland 5 Also abroad 88

5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
Where
Katowice, Warsaw, Wrocław
Age
18 years and over
People
130 worldwide
Run by
Imbria Pharmaceuticals Inc.
See details and how to join2024-515125-28-00 · EU 2024-515125-28-00
Phase 2Taking people
A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy
Where
Katowice, Warsaw, Wroclaw
Age
18 years and over
People
165 worldwide
Run by
Imbria Pharmaceuticals, Inc.
See details and how to joinNCT07023614
Phase 2/3Enrolling by invitation
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
Where
Katowice, Warsaw
Age
18 years to 85 years
People
900 worldwide
Run by
Cytokinetics
See details and how to joinNCT04848506 · EU 2023-508963-58-00
No phaseTaking people
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Where
Katowice, Warsaw
Age
18 years and over
People
1,700 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT05489705
Phase 2Taking people
MEK Inhibitors for the Treatment of Hypertrophic Cardiomyopathy in Patients With RASopathies
Where
Warsaw
Age
1 day to 18 years
People
40
Run by
Medical University of Warsaw
See details and how to joinNCT06555237